Inhibrx Stock Alpha and Beta Analysis

INBX -  USA Stock  

USD 38.64  0.52  1.33%

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Inhibrx. It also helps investors analyze the systematic and unsystematic risks associated with investing in Inhibrx over a specified time horizon. Remember, high Inhibrx's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please see Inhibrx Backtesting, Inhibrx Valuation, Inhibrx Correlation, Inhibrx Hype Analysis, Inhibrx Volatility, Inhibrx History and analyze Inhibrx Performance.

Inhibrx Beta 

Please note that although Inhibrx alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Inhibrx did 0.55  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Inhibrx stock's relative risk over its benchmark. Inhibrx has a beta of 0.14  . Let's try to break down what Inhibrx's beta means in this case. As returns on the market increase, Inhibrx returns are expected to increase less than the market. However, during the bear market, the loss on holding Inhibrx will be expected to be smaller as well.
Inhibrx Book Value per Share is fairly stable at the moment as compared to the past year. Inhibrx reported Book Value per Share of 2.99 in 2020. Tangible Assets Book Value per Share is likely to rise to 6.14 in 2021, whereas Enterprise Value over EBIT is likely to drop (16.51)  in 2021.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Inhibrx Quarterly Book Value per Share


Inhibrx Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Inhibrx market risk premium is the additional return an investor will receive from holding Inhibrx long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Inhibrx. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Inhibrx's performance over market.
α0.55   β0.14
90 days against DJI

Inhibrx expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Inhibrx's Buy-and-hold return. Our buy-and-hold chart shows how Inhibrx performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Inhibrx Market Price Analysis

Market price analysis indicators help investors to evaluate how Inhibrx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inhibrx shares will generate the highest return on investment. By understating and applying Inhibrx stock market price indicators, traders can identify Inhibrx position entry and exit signals to maximize returns.

Inhibrx Return and Market Media

The median price of Inhibrx for the period between Fri, Jul 30, 2021 and Thu, Oct 28, 2021 is 31.14 with a coefficient of variation of 12.96. The daily time series for the period is distributed with a sample standard deviation of 4.2, arithmetic mean of 32.39, and mean deviation of 3.74. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
EPS Reported08/09/2021
Inhibrx falls 5.51 percent in Active Trading on August 13 - ...08/13/2021
Inhibrx gains 4.80 percent on Moderate Volume August 18 - Eq...08/18/2021
Inhibrx gains 1.88 percent to Close at 28.76 on August 25 - ...08/25/2021
Inhibrx gains 5.60 percent on Moderate Volume September 2 - ...09/02/2021
Financial Statements09/03/2021
Inhibrx falls 3.78 percent on Moderate Volume September 20 -...09/20/2021
Inhibrx falls 2.75 percent for September 24 - Equities.com09/24/2021
Inhibrx falls 4.01 percent to Close at 31.14 on October 4 - ...10/04/2021
Inhibrx To Host Webcast Presentation of Interim Results from...10/11/2021
Financial Statements10/12/2021
Inhibrx falls 0.73 percent on Moderate Volume October 15 - E...10/15/2021

About Inhibrx Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Inhibrx has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Inhibrx Upcoming Company Events

As portrayed in its financial statements, the presentation of Inhibrx's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inhibrx's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Inhibrx's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Inhibrx. Please utilize our Beneish M Score to check the likelihood of Inhibrx's management manipulating its earnings.
Upcoming Quarterly Report12th of November 2021
Next Earnings Report11th of March 2022
Next Fiscal Quarter End30th of September 2021
Next Fiscal Year End11th of March 2022
Last Quarter Report30th of June 2021
Last Earning Announcement30th of September 2020

Build Portfolio with Inhibrx

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Inhibrx Backtesting, Inhibrx Valuation, Inhibrx Correlation, Inhibrx Hype Analysis, Inhibrx Volatility, Inhibrx History and analyze Inhibrx Performance. Note that the Inhibrx information on this page should be used as a complementary analysis to other Inhibrx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Inhibrx Stock analysis

When running Inhibrx price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Valuation
Check real value of public entities based on technical and fundamental data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Inhibrx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inhibrx technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inhibrx trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...